Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POM121 membrane glycoprotein-like 1 pseudogene (POM121L1P; ENSG00000248769) is a pseudogene homologous to the POM121 transmembrane nucleoporin gene, which encodes a core component of the nuclear pore complex[1][4][8]. Pseudogenes are non-functional genomic loci that resemble functional genes but typically lack the regulatory sequences and open reading frames necessary for protein-coding activity. There is no evidence that POM121L1P encodes a functional protein, and it is listed in databases such as NCBI as a pseudogene of unknown function[8]. As such, it is not considered a therapeutic target, has no known drug interactions, and is not annotated with specific biological functions or disease associations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POM121 membrane glycoprotein-like 1 pseudogene (POM121L1P).